19:58:07Canada

Sanofi (SNY)

NASDAQ

Key stats Fiscal year 2025

Income statement

Net income
7,813,000,000 40.5%
Gross profit
33,667,000,000
Operating income
6,344,000,000
Earnings per share
6.40 44.1%
R&D expense
7,842,000,000

Growth and profitability

Return on equity
10.95
Return on assets
6.16

Balance sheet

Total assets
126,805,000,000
Shareholders' equity
71,376,000,000
Cash and equivalents
7,657,000,000
Debt
18,702,000,000
Net debt
11,045,000,000
Current ratio
1.09
Debt to equity
0.26

Cash flow and ratios

Operating cash flow
10,750,000,000
Interest coverage
11.27

Shareholder returns

Share buybacks
5,030,000,000
Shares outstanding
1,219,427,096
Book value per share
58.53
Revenue and net income
Debt, free cash flow and cash
Earnings per share

Company information

Headquarters
Paris, I0
Exchange
NASDAQ
Fiscal year end
12-31
Industry (SEC)
Pharmaceutical Preparations

Fiscal year end: · Source: SEC EDGAR

Sanofi trades on NASDAQ under the ticker symbol SNY. This page brings together its price chart, company profile, key financial figures and technical indicators.

Company profile

Technical analysis